AngelMD AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and…
Read More
AngelMD AngelMD Portfolio Company Raydiant Oximetry Awarded FDA Breakthrough Device Status The accelerated path to approval through the breakthrough device program will enable better care to millions of mothers and…
Marker Therapeutics, Inc. TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing October 17, 2018